Institut de Cancerologie de l'Ouest (ICO) - Saint-Herblain

Saint-Herblain 44805

1 studies enrolling now · 2 studies all time

What they study most

Advanced or Metastatic Solid Tumor, Carcinoma, Non-Small-Cell Lung, Liver Failure

Studies at this site

• Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver Impairment — Recruiting now
• A Study of Tislelizumab (BGB-A317) Plus Chemoradiotherapy Followed by Tislelizumab Monotherapy in Newly Diagnosed, Stage III Subjects With Locally Advanced, Unresectable Non-small Cell Lung Cancer — Stopped early